title: Isotretinoin-associated Sweet's syndrome: a case report.
abstract: OBJECTIVE
  Sweet's syndrome (SS) is characterized by various clinical symptoms, physical features, and pathological findings. Although cases of SS are very rare, there has been an increase in the incidence of drug-induced SS. Till date, there have been only few reported cases of isotretinoin-induced SS. In this report, we describe the case of a 19-year-old girl who developed SS after systemic treatment with oral isotretinoin for nodulocystic acne.
  
  
  CONCLUSIONS
  The findings of this report emphasize the importance of evaluating isotretinoin as a possible, though uncommon, cause of SS and replacing it with another treatment if its involvement is suspected.
authors.affiliation: Department of Internal Medicine, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran. moghimi_jam@yahoo.com.
authors.forename: Jamileh
authors.initials: J
authors.lastname: Moghimi
authors.affiliation: Research Center for Social Determinants of Health, Semnan University of Medical Sciences, Semnan, Iran. dpahlevan@yahoo.com.
authors.forename: Daryiush
authors.initials: D
authors.lastname: Pahlevan
authors.affiliation: Research Center for Social Determinants of Health, Semnan University of Medical Sciences, Semnan, Iran. maryamazizzadeh@yahoo.com.
authors.forename: Maryam
authors.initials: M
authors.lastname: Azizzadeh
authors.affiliation: Department of Dermatology, School of Medicine, Arak University of Medical Sciences, Arak, Iran. hamid1348@yahoo.com.
authors.forename: Hamid
authors.initials: H
authors.lastname: Hamidi
authors.affiliation: Students' Research Committee, Semnan University of Medical Sciences, Semnan, Iran. m.pourazizi@yahoo.com.
authors.forename: Mohsen
authors.initials: M
authors.lastname: Pourazizi
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D001706:Biopsy; D003879:Dermatologic Agents / Q000009:adverse effects*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects*; D012074:Remission Induction; D012307:Risk Factors; D016463:Sweet Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D003879:Dermatologic Agents; D005938:Glucocorticoids; D015474:Isotretinoin